166 related articles for article (PubMed ID: 31688579)
1. Effects of perimenopausal transdermal estradiol on self-reported sleep, independent of its effect on vasomotor symptom bother and depressive symptoms.
Geiger PJ; Eisenlohr-Moul T; Gordon JL; Rubinow DR; Girdler SS
Menopause; 2019 Nov; 26(11):1318-1323. PubMed ID: 31688579
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
[TBL] [Abstract][Full Text] [Related]
4. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone.
Mirkin S; Graham S; Revicki DA; Bender RH; Bernick B; Constantine GD
Menopause; 2019 Jan; 26(6):637-642. PubMed ID: 30601452
[TBL] [Abstract][Full Text] [Related]
5. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.
Cohen LS; Joffe H; Guthrie KA; Ensrud KE; Freeman M; Carpenter JS; Learman LA; Newton KM; Reed SD; Manson JE; Sternfeld B; Caan B; Freeman EW; LaCroix AZ; Tinker LF; Booth-Laforce C; Larson JC; Anderson GL
Menopause; 2014 Apr; 21(4):347-54. PubMed ID: 23982113
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.
Constantine GD; Revicki DA; Kagan R; Simon JA; Graham S; Bernick B; Mirkin S
Menopause; 2019 May; 26(5):513-519. PubMed ID: 30516713
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
Shulman LP; Yankov V; Uhl K
Menopause; 2002; 9(3):195-207. PubMed ID: 11973443
[TBL] [Abstract][Full Text] [Related]
10. A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.
Lobo RA; Archer DF; Kagan R; Kaunitz AM; Constantine GD; Pickar JH; Graham S; Bernick B; Mirkin S
Obstet Gynecol; 2018 Jul; 132(1):161-170. PubMed ID: 29889748
[TBL] [Abstract][Full Text] [Related]
11. Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms.
Joffe H; de Wit A; Coborn J; Crawford S; Freeman M; Wiley A; Athappilly G; Kim S; Sullivan KA; Cohen LS; Hall JE
J Clin Endocrinol Metab; 2020 Mar; 105(3):e642-50. PubMed ID: 31693131
[TBL] [Abstract][Full Text] [Related]
12. [The effect of transdermal hormone replacement therapy on vasomotor symptoms in perimenopausal women].
Rozmus-Warcholińska W; Skrzypulec V; Drosdzol A; Kowalczyk R; Nowosielski K; Piela B; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():254-8. PubMed ID: 15884251
[TBL] [Abstract][Full Text] [Related]
13. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
Soares CN; Arsenio H; Joffe H; Bankier B; Cassano P; Petrillo LF; Cohen LS
Menopause; 2006; 13(5):780-6. PubMed ID: 16894334
[TBL] [Abstract][Full Text] [Related]
14. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition.
Joffe H; Petrillo LF; Koukopoulos A; Viguera AC; Hirschberg A; Nonacs R; Somley B; Pasciullo E; White DP; Hall JE; Cohen LS
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1044-54. PubMed ID: 21525161
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
Ruiz AD; Daniels KR
Int J Pharm Compd; 2014; 18(1):70-7. PubMed ID: 24881343
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.
Gordon JL; Rubinow DR; Watkins L; Hinderliter AL; Caughey MC; Girdler SS
J Clin Endocrinol Metab; 2020 May; 105(5):e2050-60. PubMed ID: 31838497
[TBL] [Abstract][Full Text] [Related]
17. Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.
Schmidt PJ; Ben Dor R; Martinez PE; Guerrieri GM; Harsh VL; Thompson K; Koziol DE; Nieman LK; Rubinow DR
JAMA Psychiatry; 2015 Jul; 72(7):714-26. PubMed ID: 26018333
[TBL] [Abstract][Full Text] [Related]
18. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
Guthrie KA; LaCroix AZ; Ensrud KE; Joffe H; Newton KM; Reed SD; Caan B; Carpenter JS; Cohen LS; Freeman EW; Larson JC; Manson JE; Rexrode K; Skaar TC; Sternfeld B; Anderson GL
Obstet Gynecol; 2015 Aug; 126(2):413-422. PubMed ID: 26241433
[TBL] [Abstract][Full Text] [Related]
19. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
[TBL] [Abstract][Full Text] [Related]
20. Use of a levonorgestrel-containing intrauterine system with supplemental estrogen improves symptoms in perimenopausal women: a pilot study.
Santoro N; Teal S; Gavito C; Cano S; Chosich J; Sheeder J
Menopause; 2015 Dec; 22(12):1301-7. PubMed ID: 26575111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
